Medical Advocates

Z
idovudine (Retrovir)
 
Conference Citations
 
6th IAS Conference
18th CROI

XVIII International AIDS Conference

5th IAS Conference

16th CROI

XVII International AIDS Conference

15th CROI

14th CROI




Conference Archives

ZDV Main Page Main New/Newsworthy  Home Page      

Last Update:  August 05, 2011
 Documents identified with this icon are in Portable Document Format (PDF) and require the Adobe Acrobat Reader
Perinatal Journal Data are integrated with Perinatal Conference Data in the Perinatal Data Page. Pediatric Journal Data
are integrated with Pediatric Conference Data in the Pediatric Data Pag
e
6th IAS Conference on HIV and Pathogenesis
 


18th Conference on Retroviruses and
Opportunistic Infections

  • POSTER
    Effectiveness of Maternal HAART vs ZDV to Prevent MTCT in a Programmatic Setting: Botswana
    S Dryden-Peterson, O Jayeoba, H Jibril, et al
    PDF Poster     Abstract
  • POSTER
    Pharmacokinetics of ZDV Dosed Twice-daily according to WHO Weight-bands in African HIV-1+ Children
    Q Fillekes, L Kendall, S Kitaka, et al
    PDF Poster     Abstract

XVIII International AIDS Conference
 

  • POSTER
    Substitution of zidovudine for stavudine - outcome in India
    K. Raja, R. Lakshmanabharathi, B.A. Mohamed Batcha,  et al
    PDF Poster
         Abstract
  • POSTER
    A strategy to reduce new HIV infection, prevention and treatment: prolong release
    anti-HIV polymeric vaginal film - it's in vivo and in vitro drug release study
    B.B. Bhowmik, A. Chatterjee, R. Thakuriam et al

    PDF Poster
         Abstract
  • POSTER
    Neutropenia during 216 weeks of AZT-based anti-retroviral therapy among HIV infected
    patients in Africa in the DART trial
    F. Ssali, J. Kayiwa, S. Walker, et al

    PDF Poster
         Abstract

5th IAS Conference on HIV and Pathogenesis
 

  • POSTER
    Prevalence of zidovudine-induced anemia using laboratory monitoring in HIV/AIDS in Jos, Nigeria
    C. Ramyil, I. Hauwa, L. Chindak, et al

    PDF Poster     Abstract

16th Conference on Retroviruses and
Opportunistic Infections

  • POSTER
    High-dose Zidovudine + Valganciclovir in the Treatment of Kaposi’s Sarcoma-associated Herpesvirus-
    associated Multicentric Castleman’s Disease: A Targeted Therapy Using Antiviral Drugs that Are |
    Activated to Toxic Moieties by Kaposi’s Sarcoma-associated Herpesvirus Lytic Genes

    T Uldrick, D O'Mahoney, K Aleman, et al
    PDF Poster     Abstract

XVII International AIDS Conference
 


15th Conference on Retroviruses and
Opportunistic Infections


14th Conference on Retroviruses and
Opportunistic Infections


ZDV Main Page Main New/Newsworthy  Home Page      

Zidovudine Conference Citations